CLINICAL_TRIALS ClinicalTrials.gov record update

The OPTIMAL TDM Study: Determining Optimal Beta-lactam Plasma Concentrations Through Therapeutic Drug Monitoring

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03790631
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:47.114984+00:00
Published At: 2025-05-20T00:00:00+00:00
Record Updated At: 2025-05-20
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Beta-lactam Antibiotics", "Therapeutic Drug Monitoring", "Toxicity", "Efficacy", "Imipenem", "Meropenem", "Piperacillin", "Flucloxacillin", "Amoxicillin", "Ceftazidime", "Cefepime"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-05-20"
protocolSection.identificationModule.nctId: "NCT03790631"
protocolSection.identificationModule.officialTitle: "The OPTIMAL TDM Study: Determining Optimal Beta-lactam Plasma Concentrations Through Therapeutic Drug Monitoring"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.